ROYALTY PHARMA PLC- CL A (RPRX) Stock News
NASDAQ:RPRX - Nasdaq - GB00BMVP7Y09 - Common Stock - Currency: USD
RPRX Latest News, Press Relases and Analysis
Royalty Pharma Completes the Acquisition of Its External Manager
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has successfully closed the acquisition of its...
Royalty Pharma Completes the Acquisition of Its External Manager
Royalty Pharma to Present at Upcoming Investor Conferences
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor...
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
Sector ETF report for FXH
Royalty Pharma to Present at Upcoming Investor Conferences
Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition
Received overwhelming shareholder approval with 99.9% of votes cast in favorSimplified structure benefits shareholders through strengthened shareholder...
Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition
Royalty Pharma (RPRX) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Royalty Pharma (RPRX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Royalty Pharma (RPRX) Surpasses Q1 Earnings and Revenue Estimates
Royalty Pharma (RPRX) delivered earnings and revenue surprises of 7.07% and 5.72%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: SEER
Royalty Pharma Reports First Quarter 2025 Results
Portfolio Receipts growth of 17% to $839 million; Royalty Receipts growth of 12%Net cash provided by operating activities of $596 millionRaised full year...
Royalty Pharma Reports First Quarter 2025 Results
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Royalty Pharma (RPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: HLI
Alerus (ALRS) Q1 Earnings and Revenues Top Estimates
Alerus (ALRS) delivered earnings and revenue surprises of 30.23% and 5.42%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: ALRS
Royalty Pharma PLC (RPRX) Surged Following an Acquisition Announcement
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. 2025 got out to a solid start with the market hitting all-time highs in mid-February. However, a dramatic reversal pushed the S&P 500 down 8.7%, closing the […]
Royalty Pharma Declares Second Quarter 2025 Dividend
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the...
Royalty Pharma Declares Second Quarter 2025 Dividend
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2025 financial...
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025
Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company’s Board...
Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors
Is Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now?
We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at where Royalty Pharma plc (NASDAQ:RPRX) stands against other most profitable biotech stocks to buy right now. With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry […]
Is Royalty Pharma Plc (RPRX) the Most Undervalued Healthcare Stock to Buy According to Analysts?
We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Royalty Pharma Plc (NASDAQ:RPRX) stands against other most undervalued healthcare stocks to buy according to analysts. Rising Healthcare Costs and the Impact of Tariffs on US-China Trade […]
4 Healthcare Stocks With Massive Gains—and More to Come
Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.
Royalty Pharma Announces Upcoming Investor Day
NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will host an Investor Day in New York City on...